APC and malignant colon neoplasm: In colon cancer, mutation of the APC tumor suppressor activates β‐Catenin/Tcf signaling, leading to transcriptional induction of c‐myc and cyclin D1 in colon cancer 13, 15 illustrating the oncogenic potential of this signal transduction pathway.